Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

BIOA

BioAge Labs Inc.

Oct 11 • 02:40PM ET

21.29

Dollar change +0.75
Percentage change 3.65	%

Healthcare • Drug Manufacturers - Specialty & Generic • USA • NASD

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-	Insider Own	23.85%	Shs Outstand	34.17M	Perf Week	-2.74%
Market Cap	727.48M	Forward P/E	-	EPS next Y	-	Insider Trans	47.81%	Shs Float	26.02M	Perf Month	-
Income	-	PEG	-	EPS next Q	-	Inst Own	14.69%	Short Float	0.73%	Perf Quarter	-
Sales	-	P/S	-	EPS this Y	-	Inst Trans	-	Short Ratio	0.22	Perf Half Y	-
Book/sh	-5.77	P/B	-	EPS next Y	-	ROA	-	Short Interest	0.19M	Perf Year	-
Cash/sh	4.66	P/C	4.57	EPS next 5Y	-	ROE	-	52W Range	18.30 - 24.00	Perf YTD	16.28%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-11.29%	Beta	-
Dividend TTM	-	Quick Ratio	12.61	Sales past 5Y	0.00%	Gross Margin	-	52W Low	16.34%	ATR (14)	2.19
Dividend Ex-Date	-	Current Ratio	12.61	EPS Y/Y TTM	-	Oper. Margin	-	RSI (14)	-	Volatility	7.88% -
Employees	-	Debt/Eq	0.08	Sales Y/Y TTM	-	Profit Margin	-	Recom	-	Target Price	-
Option/Short	No / Yes	LT Debt/Eq	0.04	EPS Q/Q	-	Payout	-	Rel Volume	0.30	Prev Close	20.54
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	-	Earnings	-	Avg Volume	867.56K	Price	21.29
SMA20	2.52%	SMA50	2.52%	SMA200	2.52%	Trades		Volume	211,968	Change	3.65%

Oct-07-24 09:10PM	RA Capital Management, L.P. Acquires New Stake in Bioage Labs Inc (GuruFocus.com)
Oct-05-24 07:15AM	3 Reasons to Buy BioAge Labs Stock Hand Over Fist in October (Motley Fool)
Oct-03-24 09:05AM	This IPO Biotech Stock Could Be the Next Eli Lilly (Motley Fool) +5.73%
Oct-01-24 04:30PM	BioAge Labs Announces Closing of Initial Public Offering, Full Exercise of Underwriters' Option to Purchase Additional Shares and Closing of the Concurrent Private Placement (GlobeNewswire)
Sep-26-24 04:08PM	BioAge Labs, An Obesity Newcomer And Eli Lilly Partner, Rises On Upsized IPO (Investor's Business Daily)
02:36PM	Loading…
02:36PM	A weight loss drug developer's stock soars after a $198 million IPO (Quartz)
08:25AM	BioAge Labs IPO: Stock price will be closely watched today as the obesity drug developer debuts on the Nasdaq (FastCompany)
Sep-25-24 08:00PM	BioAge Labs Announces Pricing of Upsized Initial Public Offering (GlobeNewswire)
04:13PM	BioAge prices $198M IPO, validating pivot to obesity drug research (BioPharma Dive)
11:27AM	A weight loss drug maker is aiming for a big IPO (Quartz)

BioAge Labs, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapeutic products for metabolic diseases, such as obesity, by targeting the biology of human beings. It offers Azelaprag, a potential oral therapeutic for obesity, followed by several earlier-stage metabolic programs. The company was founded by Kristen Fortney and Eric Morgen on April 1, 2015 and is headquartered in Richmond, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Pande Vijay Satyanand	Director	Oct 01 '24	Buy	19.73	126,793	2,501,626	1,026,793	Oct 03 07:19 PM
Pande Vijay Satyanand	Director	Oct 02 '24	Buy	19.73	67,096	1,323,804	1,093,889	Oct 03 07:19 PM
Pande Vijay Satyanand	Director	Oct 03 '24	Buy	19.90	25,306	503,589	1,119,195	Oct 03 07:19 PM
Cormorant Asset Management, LP	Former 10% Owner	Sep 27 '24	Buy	18.00	450,000	8,100,000	1,629,529	Oct 01 04:01 PM
Pande Vijay Satyanand	Director	Sep 27 '24	Buy	18.00	900,000	16,200,000	900,000	Sep 27 04:28 PM
ENRIGHT PATRICK G	Director	Sep 27 '24	Buy	18.00	400,000	7,200,000	1,710,589	Sep 27 04:26 PM
HEALY JAMES	Director	Sep 27 '24	Buy	18.00	666,665	11,999,970	2,227,124	Sep 27 04:22 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BIOA

BioAge Labs Inc.

Upgrade your FINVIZ experience